Morgan Stanley Insight IR holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Morgan Stanley Insight Fund Class IR MBIRX
- NAV / 1-Day Return 56.73 / −1.72 %
- Total Assets 1.1B
-
Adj. Expense Ratio
0.850%
- Expense Ratio 0.820%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Large Growth
- Investment Style Mid Growth
- Min. Initial Investment 10M
- Status Open
- TTM Yield 0.00
- Turnover 48%
USD | NAV as of Aug 19, 2026 | 1-Day Return as of Aug 19, 2026, 12:13 AM GMT+0
Morningstar’s Analysis MBIRX
Will MBIRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 64.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Cloudflare Inc | 13.20 | 163M | Technology |
Royalty Pharma PLC Class A | 7.80 | 96M | Healthcare |
Tesla Inc | 7.62 | 94M | Consumer Cyclical |
Affirm Holdings Inc Ordinary Shares - Class A | 6.45 | 80M | Financial Services |
IonQ Inc | 5.68 | 70M | Technology |
AppLovin Corp Ordinary Shares - Class A | 5.06 | 62M | Communication Services |
Space Exploration Technologies Corp Class A | 4.86 | 60M | Industrials |
Opendoor Technologies Inc Ordinary Shares - Class A | 4.75 | 59M | Real Estate |
Aurora Innovation Inc Class A | 4.72 | 58M | Consumer Cyclical |
Roivant Sciences Ltd Ordinary Shares | 4.58 | 56M | Healthcare |